Bim/BOD (IN) Polyclonal Antibody

Members in the Bcl-2 family are critical regulators of apoptosis by either inhibiting or promoting cell death. Bim/BOD is a group of three splice variants, BimEL, BimL and BimS, with apparent molecular masses of ~23, 16, and 13 kDa, respectively. Bcl-2 homology 3 (BH₃) domain is a potent death domain. BH₃ domain containing pro-apoptotic proteins, including Bad, Bax, Bid, Bik, and Hrk, form a growing subclass of the Bcl-2 family. A novel BH₃ domain containing protein was recently identified and designated Bim or BOD in human, mouse, and rat.^1,2 Bim/BOD interacts with diverse members in the pro-survival Bcl-2 sub-family including Bcl-2, Bcl-xL and Bcl-w. Bim/BOD induces apoptosis. The messenger RNA of Bim is ubiquitously expressed in multiple tissues and cell lines.^1,2 Cayman’s Bim/BOD (IN) Polyclonal Antibody can be used for Immunohistochemistry (IHC) and Western blot (WB) applications.

WARNING This product is not for human or veterinary use.

1. O'Connor, L., Strasser, A., O'Reilly, L.A., et al. Bim: A novel member of the Bcl-2 family that promotes apoptosis. EMBO J. 17, 384-395 (1998).

2. Hsu, S.Y., Lin, P., and Hsueh, A.J.W. BOD (Bcl-2-related ovarian death gene) is an ovarian BH₃ domain-containing proapoptotic Bcl-2 protein capable of dimerization with diverse antiapoptotic Bcl-2 members. Mol. Endocrinol. 12, 1432-1440 (1998).